---
title: "MDK upregulation via WTAP/m6A/YTHDF1 promotes metastasis in clear cell renal cell carcinoma"
id: "pubmed-43067604"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-43067604"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/43067604/"
doi: "10.1186/s43556-026-00665-4"
published_at: "2026-11-22T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# MDK upregulation via WTAP/m6A/YTHDF1 promotes metastasis in clear cell renal cell carcinoma
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-43067604
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/43067604/)
- **DOI:** [10.1186/s43556-026-00665-4](https://doi.org/10.1186%2Fs43556-026-00665-4)
- **Published At:** 2026-11-22T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- Investigators used single-cell RNA sequencing on primary tumours from patients with metastatic and non-metastatic **ccRCC** to compare cellular programs and the tumour microenvironment. - The analysis identified **Midkine (MDK)** as a molecular signature associated with tumour progression and poorer prognosis in the dataset. - MDK expression was markedly higher in metastatic ccRCC samples, with the strongest signals in PT and dPT1 tumour cell lineages. - Data indicated MDK mediated intercellular crosstalk between tumour cells and M2-like macrophage subtypes, pointing to a macrophage-centred microenvironmental axis. - The M2-like macrophages engaged CD8+ T cells via SPP1 and CD24 interactions, which the authors reported could reflect an immunosuppressive mechanism within metastatic tumours. - CD8+ T cells from metastatic samples showed upregulated genes enriched for chemokine receptor–chemokine interactions and IL-10 signalling pathways. - Mechanistic experiments reported that **WTAP** enhanced **m6A** methylation on MDK mRNA and increased MDK mRNA stability by facilitating **YTHDF1** binding, producing higher MDK protein levels. - The increased MDK protein was associated with ccRCC cell proliferation, invasion, metastasis, epithelial–mesenchymal transition, and reduced apoptosis in the reported models. - Authors proposed an MDK-centred immunosuppressive axis and a regulatory pathway — WTAP/m6A/YTHDF1 → MDK — that drives malignant progression in metastatic **ccRCC**. - The study team suggested **MDK** as a candidate prognostic biomarker and a potential therapeutic target for metastatic ccRCC. - The source reported that human tissue protocols received institutional ethics approval and that all patients gave written consent; animal protocols were also approved. - The article did not report specific therapeutic dosing, clinical trial data, or enumerated limitations and next regulatory milestones in the abstract.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/43067604/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43067604%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/43067604/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/43067604/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/43067604/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/43067604/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/43067604/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/43067604/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43067604%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43067604%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/43067604/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43067604/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43067604/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/43067604/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43067604/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/43067604/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/43067604/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/43067604/#conflict-of-interest) * [ References ](https://pubmed.ncbi.nlm.nih.gov/43067604/#references) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/43067604/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/43067604/#substances) * [ Grants and funding ](https://pubmed.ncbi.nlm.nih.gov/43067604/#grants) Title & authors Abstract Conflict of interest statement References MeSH terms Substances Grants and funding Mol Biomed Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Mol+Biomed%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Mol+Biomed%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43067604/) . 2026 Nov 22;7(1):257. doi: 10.1186/s43556-026-00665-4. # WTAP/m6A/YTHDF1-mediated upregulation of Midkine expression drives clear cell renal cell carcinoma metastasis: insights from single-cell sequencing [Xinbao Yin](https://pubmed.ncbi.nlm.nih.gov/?term=Yin+X&cauthor_id=43067604)[#](https://pubmed.ncbi.nlm.nih.gov/43067604/#full-view-equal-contrib-explanation "Contributed equally")[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43067604/#full-view-affiliation-1 "Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China."), [Zhaofeng Li](https://pubmed.ncbi.nlm.nih.gov/?term=Li+Z&cauthor_id=43067604)[#](https://pubmed.ncbi.nlm.nih.gov/43067604/#full-view-equal-contrib-explanation "Contributed equally")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43067604/#full-view-affiliation-2 "Medical School, Nantong University, Nantong University, Nantong, 226001, China."), [Han Yang](https://pubmed.ncbi.nlm.nih.gov/?term=Yang+H&cauthor_id=43067604)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43067604/#full-view-affiliation-1 "Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.")[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43067604/#full-view-affiliation-3 "Department of Urology, The First Affiliated Hospital \(Southwest Hospital, Army Medical University, Chongqing, China."), [Kai Zhao](https://pubmed.ncbi.nlm.nih.gov/?term=Zhao+K&cauthor_id=43067604)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43067604/#full-view-affiliation-1 "Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China."), [Guanqun Zhu](https://pubmed.ncbi.nlm.nih.gov/?term=Zhu+G&cauthor_id=43067604)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43067604/#full-view-affiliation-1 "Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China."), [Zongliang Zhang](https://pubmed.ncbi.nlm.nih.gov/?term=Zhang+Z&cauthor_id=43067604)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43067604/#full-view-affiliation-1 "Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China."), [Xunhua Li](https://pubmed.ncbi.nlm.nih.gov/?term=Li+X&cauthor_id=43067604)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43067604/#full-view-affiliation-1 "Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China."), [Ying Wang](https://pubmed.ncbi.nlm.nih.gov/?term=Wang+Y&cauthor_id=43067604)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/43067604/#full-view-affiliation-4 "Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin, P.R. China. yingwang0727@outlook.com."), [Xueping Zheng](https://pubmed.ncbi.nlm.nih.gov/?term=Zheng+X&cauthor_id=43067604)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/43067604/#full-view-affiliation-5 "Department of Geriatric Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China. simplexueping@163.com."), [Ke Wang](https://pubmed.ncbi.nlm.nih.gov/?term=Wang+K&cauthor_id=43067604)[ 6 ](https://pubmed.ncbi.nlm.nih.gov/43067604/#full-view-affiliation-6 "Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. wangke@qdu.edu.cn.") Affiliations Expand ### Affiliations * 1 Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. * 2 Medical School, Nantong University, Nantong University, Nantong, 226001, China. * 3 Department of Urology, The First Affiliated Hospital (Southwest Hospital, Army Medical University, Chongqing, China. * 4 Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin, P.R. China. yingwang0727@outlook.com. * 5 Department of Geriatric Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China. simplexueping@163.com. * 6 Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. wangke@qdu.edu.cn. # Contributed equally. * PMID: **43067604** * DOI: [ 10.1186/s43556-026-00665-4 ](https://doi.org/10.1186/s43556-026-00665-4) Item in Clipboard # WTAP/m6A/YTHDF1-mediated upregulation of Midkine expression drives clear cell renal cell carcinoma metastasis: insights from single-cell sequencing Xinbao Yin et al. Mol Biomed. 2026. Show details Display options Display options Format Abstract PubMed PMID Mol Biomed Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Mol+Biomed%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Mol+Biomed%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43067604/) . 2026 Nov 22;7(1):257. doi: 10.1186/s43556-026-00665-4. ### Authors [Xinbao Yin](https://pubmed.ncbi.nlm.nih.gov/?term=Yin+X&cauthor_id=43067604)[#](https://pubmed.ncbi.nlm.nih.gov/43067604/#short-view-equal-contrib-explanation "Contributed equally")[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43067604/#short-view-affiliation-1 "Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China."), [Zhaofeng Li](https://pubmed.ncbi.nlm.nih.gov/?term=Li+Z&cauthor_id=43067604)[#](https://pubmed.ncbi.nlm.nih.gov/43067604/#short-view-equal-contrib-explanation "Contributed equally")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43067604/#short-view-affiliation-2 "Medical School, Nantong University, Nantong University, Nantong, 226001, China."), [Han Yang](https://pubmed.ncbi.nlm.nih.gov/?term=Yang+H&cauthor_id=43067604)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43067604/#short-view-affiliation-1 "Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.")[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43067604/#short-view-affiliation-3 "Department of Urology, The First Affiliated Hospital \(Southwest Hospital, Army Medical University, Chongqing, China."), [Kai Zhao](https://pubmed.ncbi.nlm.nih.gov/?term=Zhao+K&cauthor_id=43067604)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43067604/#short-view-affiliation-1 "Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China."), [Guanqun Zhu](https://pubmed.ncbi.nlm.nih.gov/?term=Zhu+G&cauthor_id=43067604)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43067604/#short-view-affiliation-1 "Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China."), [Zongliang Zhang](https://pubmed.ncbi.nlm.nih.gov/?term=Zhang+Z&cauthor_id=43067604)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43067604/#short-view-affiliation-1 "Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China."), [Xunhua Li](https://pubmed.ncbi.nlm.nih.gov/?term=Li+X&cauthor_id=43067604)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43067604/#short-view-affiliation-1 "Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China."), [Ying Wang](https://pubmed.ncbi.nlm.nih.gov/?term=Wang+Y&cauthor_id=43067604)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/43067604/#short-view-affiliation-4 "Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin, P.R. China. yingwang0727@outlook.com."), [Xueping Zheng](https://pubmed.ncbi.nlm.nih.gov/?term=Zheng+X&cauthor_id=43067604)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/43067604/#short-view-affiliation-5 "Department of Geriatric Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China. simplexueping@163.com."), [Ke Wang](https://pubmed.ncbi.nlm.nih.gov/?term=Wang+K&cauthor_id=43067604)[ 6 ](https://pubmed.ncbi.nlm.nih.gov/43067604/#short-view-affiliation-6 "Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. wangke@qdu.edu.cn.") ### Affiliations * 1 Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. * 2 Medical School, Nantong University, Nantong University, Nantong, 226001, China. * 3 Department of Urology, The First Affiliated Hospital (Southwest Hospital, Army Medical University, Chongqing, China. * 4 Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin, P.R. China. yingwang0727@outlook.com. * 5 Department of Geriatric Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China. simplexueping@163.com. * 6 Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. wangke@qdu.edu.cn. # Contributed equally. * PMID: **43067604** * DOI: [ 10.1186/s43556-026-00665-4 ](https://doi.org/10.1186/s43556-026-00665-4) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancer. It is highly heterogeneous and exhibits a pronounced tendency towards haematogenous metastasis, which together contribute to poor overall survival. The molecular and cellular programs that distinguish metastatic from non-metastatic primary ccRCC remain incompletely defined. Here, through single-cell RNA sequencing of primary tumours from non-metastatic and metastatic ccRCC patients, we revealed marked differences in the tumour microenvironment and identified Midkine (MDK) as a molecular signature associated with ccRCC progression and poor prognosis. MDK was significantly upregulated in metastatic ccRCC, particularly in PT and dPT1 tumour cell lineages, and mediated crosstalk between tumour cells and M2-like macrophage subtypes. These macrophages in turn interacted with CD8 + T cells through SPP1 and CD24, suggesting a potential immunosuppressive mechanism. The genes upregulated in CD8 + T cells from metastatic ccRCC patients were enriched in chemokine receptor-chemokine interactions and IL-10 signalling. Mechanistically, WTAP promoted m6A methylation of MDK mRNA and increased its stability by facilitating YTHDF1 binding, thus increasing MDK protein levels and driving ccRCC cell proliferation, invasion, metastasis, and epithelial-mesenchymal transition while inhibiting apoptosis. These findings define an MDK-centred immunosuppressive axis and a WTAP/m6A/YTHDF1/MDK regulatory pathway that promotes ccRCC malignant progression, highlighting MDK as a potential prognostic biomarker and therapeutic target for metastatic ccRCC. **Keywords:** MDK; WTAP; Metastatic tumour; Single-cell RNA sequencing; ccRCC; m6A methylation. © 2026. The Author(s). [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement Declarations. Ethics approval and consent to participate: This research project has been conducted in accordance with the ethical principles and guidelines established by the Institutional Ethics Committee for Clinical Research of the Affiliated Hospital of Qingdao University. Participants were provided with detailed information about the research, its objectives, potential risks, and benefits, and they voluntarily agreed to participate. The research has been conducted with high level of integrity, and data collection, analysis, and reporting have been carried out in a transparent and accurate manner. The studies involving human renal tumour tissue samples were approved by the ethical committees of the Affiliated Hospital of Qingdao University (No: QYFYWZLL26556). All patients gave their written consent. All animal study protocols were approved by the Ethics Committee of the Medical Animal Laboratory of the Affiliated Hospital of Qingdao University (No: AHQU-MAL 20221209LZF). Consent for publication: Not applicable. Competing interests: The authors have no conflicts of interest to declare that are relevant to the content of this article. ## References 1. 1. Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam JA, et al. Epidemiology of Renal Cell Carcinoma: 2022 Update. Eur Urol. 2022;82(5):529–42. . - [DOI](https://doi.org/10.1016/j.eururo.2022.08.019) - [PubMed](https://pubmed.ncbi.nlm.nih.gov/36100483/) 2. 1. Siegel RL, Kratzer TB, Wagle NS, Sung H, Jemal A. Cancer statistics, 2026. CA Cancer J Clin. 2026;76(1):e70043. . - [DOI](https://doi.org/10.3322/caac.70043) - [PubMed](https://pubmed.ncbi.nlm.nih.gov/41528114/) - [PMC](https://pmc.ncbi.nlm.nih.gov/articles/12798275/) 3. 1. Tur J, Webster RM. The renal cell carcinoma drug market. Nat Rev Drug Discov. 2024;23(1):16–7. . - [DOI](https://doi.org/10.1038/d41573-023-00186-7) - [PubMed](https://pubmed.ncbi.nlm.nih.gov/37990041/) 4. 1. Novacescu D, Feciche BO, Cumpanas AA, Bardan R, Rusmir AV, Bitar YA, et al. Contemporary Clinical Definitions, Differential Diagnosis, and Novel Predictive Tools for Renal Cell Carcinoma. Biomedicines. 2022;10(11):2926. . - [DOI](https://doi.org/10.3390/biomedicines10112926) - [PubMed](https://pubmed.ncbi.nlm.nih.gov/36428491/) - [PMC](https://pmc.ncbi.nlm.nih.gov/articles/9687297/) 5. 1. Rizzo M, Pezzicoli G, Tibollo V, Premoli A, Quaglini S. Clinical outcome predictors for metastatic renal cell carcinoma: a retrospective multicenter real-life case series. BMC Cancer. 2024;24(1):804. . - [DOI](https://doi.org/10.1186/s12885-024-12572-4) - [PubMed](https://pubmed.ncbi.nlm.nih.gov/38970
## Related Clinical Research

- [NAMPT and NAD+ in Health and Disease: Molecular Roles and Therapeutic Challenges](https://medichelpline.com/clinical-feed/pubmed-43067627.md) (DOI: 10.1186/s43556-026-00666-3)
- [Eukaryotic pol ζ/Rev1 complex drives CG-to-GC transversions and large mutator effect](https://medichelpline.com/clinical-feed/biorxiv-1-minimal-eukaryotic-dna-polymerase-zeta-rev1-gc-pair-mutasome.md)
- [Sacituzumab tirumotecan versus physician's choice in previously treated endometrial cancer — phase](https://medichelpline.com/clinical-feed/pubmed-42933460.md) (DOI: 10.1016/S0140-6736(26)02099-4)
- [Early STAT+ Results for Alterome’s KRAS Inhibitor in Pancreatic, Lung, and Colorectal Cancer](https://medichelpline.com/clinical-feed/stat-news-1-stat-early-results-for-alterome-s-kras-drug-for-pancreas-lung-and-colon-cancer.md)
- [Circulating immune signatures during pembrolizumab-based neoadjuvant therapy in early triple-negat](https://medichelpline.com/clinical-feed/medrxiv-21-circulating-immune-dynamics-during-neoadjuvant-chemoimmunotherapy-in-early.md)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.